The company completed a $23.9m capital raise last year to reset its balance sheet.
Part of software company’s capital raise conditional on shareholder approval.
Changes to pricing model, fees possible as platform expands.
No purchase price disclosed.
FMA annual report noted scale benefits were still not being passed on.
Changes welcomed by the market after milk processor’s hefty loss.
Average fees per active member rose to $240, the largest jump in years.
After initial denial, capital raise reveals strong demand for biotech's stock.
NZ unit to become part of global asset manager focused on high-net-worth clients.
ANALYSIS: Craigs Investment Partners private wealth research head Mark Lister on the week ahead.
